Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

263 ARTíCULOS , VIENDO DEL 211 AL 225

PUBMED

Association of CAG Repeats With Long-term Progression in Huntington Disease.

Langbehn DR, Stout JC, Gregory S, Mills JA, Durr A, Leavitt BR, Roos RAC, Long JD, Owen G, Johnson HJ, Borowsky B, Craufurd D, Reilmann R, Landwehrmeyer GB, Scahill RI, Tabrizi SJ; TRACK-HD and Track-

JAMA Neurol. 2019 Aug 12. doi: 10.1001/jamaneurol.2019.2368. [Epub ahead of print]

0

0

0

PUBMED

Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models.

Toledo-Sherman L, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Cox HC, McAllister G, Penrose SD, Vater H, Esmieu W, Van de Poël A, Van de Bospoort R, Strijbosch

J Med Chem. 2019 Mar 28;62(6):2988-3008. doi: 10.1021/acs.jmedchem.8b01819. Epub 2019 Mar 19.

0

0

0

PUBMED

The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.

Anderson KE, Eberly S, Marder KS, Oakes D, Kayson E, Young A, Shoulson I; PHAROS Investigators..

Clin Genet. 2019 May 15. doi: 10.1111/cge.13529. [Epub ahead of print]

0

0

0

PUBMED

Brain compensation during visuospatial working memory in premanifest Huntington's disease.

Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N.

Neuropsychologia. 2019 Nov 14;136:107262. doi: 10.1016/j.neuropsychologia.2019.107262. [Epub ahead of print]

0

0

0

PUBMED

Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.

Estrada-Sánchez AM, Blake CL, Barton SJ, Howe AG, Rebec GV.

J Neurophysiol. 2019 Dec 1;122(6):2621-2629. doi: 10.1152/jn.00777.2018. Epub 2019 Nov 6.

0

0

0

PUBMED

Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease.

Passoni A, Favagrossa M, Colombo L, Bagnati R, Gobbi M, Diomede L, Birolini G, Di Paolo E, Valenza M, Cattaneo E, Salmona M.

ACS Chem Neurosci. 2020 Feb 5;11(3):367-372. doi: 10.1021/acschemneuro.9b00581. Epub 2020 Jan 7.

0

0

0

PUBMED

Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease.

Lessard-Beaudoin M, Yu-Taeger L, Laroche M, Singer E, Riess O, Nguyen HHP, Graham RK.

Neurobiol Dis. 2019 Feb 6;125:219-231. doi: 10.1016/j.nbd.2019.02.002. [Epub ahead of print]

0

0

0

PUBMED

Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.

Radovanović S, Vodopić S, Stanković I, Dragašević-Mišković N, Kostić V.

Int J Neurosci. 2019 Oct 2:1-8. doi: 10.1080/00207454.2019.1667781. [Epub ahead of print]

0

0

0

PUBMED

Stem cells in animal models of Huntington disease: A systematic review.

Colpo GD, Stimming EF, Teixeira AL.

Mol Cell Neurosci. 2019 Jan 24. pii: S1044-7431(18)30391-9. doi: 10.1016/j.mcn.2019.01.006. [Epub ahead of print] Review.

0

0

0

PUBMED

Corrigendum to Restless legs syndrome in NKX2-1-related chorea: An expansion of the disease spectrum" [Brain Dev. 41 (2019) 250-256]."

Iodice A, Carecchio M, Zorzi G, Garavaglia B, Spagnoli C, Salerno GG, Frattini D, Mencacci NE, Invernizzi F, Veneziano L, Mantuano E, Angriman M, Fusco C.

Brain Dev. 2019 Aug;41(7):643. doi: 10.1016/j.braindev.2019.04.011. Epub 2019 Apr 30. No abstract available.

0

0

0

PUBMED

Erucic acid, a nutritional PPARδ-ligand may influence Huntington's disease pathogenesis.

Altinoz MA, Ozpinar A, Ozpinar A, Hacker E.

Metab Brain Dis. 2020 Jan;35(1):1-9. doi: 10.1007/s11011-019-00500-6. Epub 2019 Oct 17. Review.

0

0

0

PUBMED

Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease.

Garcia-Miralles M, Yusof NABM, Tan JY, Radulescu CI, Sidik H, Tan LJ, Belinson H, Zach N, Hayden MR, Pouladi MA.

Mol Neurobiol. 2019 Jun;56(6):4464-4478. doi: 10.1007/s12035-018-1393-1. Epub 2018 Oct 17.

0

0

0

PUBMED

Targeting Huntingtin Expression in Patients with Huntington's Disease.

Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, Wild EJ, Saft C, Barker RA, Blair NF, Craufurd D, Priller J, Rickards H, Rosser A, Kordasiewicz HB, Czech C, Swayze EE, Norris DA, Baumann T, Gerlach I, Schob

N Engl J Med. 2019 May 6. doi: 10.1056/NEJMoa1900907. [Epub ahead of print]

0

0

0

PUBMED

Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease.

Crapser JD, Ochaba J, Soni N, Reidling JC, Thompson LM, Green KN.

Brain. 2019 Dec 17. pii: awz363. doi: 10.1093/brain/awz363. [Epub ahead of print]

0

0

0

PUBMED

Induced pluripotent stem cells from Huntington's disease patients: a promising approach to define and correct disease-related alterations.

Fatima A, Gutiérrez-Garcia R, Vilchez D.

Neural Regen Res. 2019 May;14(5):769-770. doi: 10.4103/1673-5374.249223. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy